Rogério Vivaldi Coelho
Chief Executive Officer presso SIGILON THERAPEUTICS, INC.
Patrimonio netto: 514 910 $ in data 31/07/2023
Posizioni attive di Rogério Vivaldi Coelho
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SIGILON THERAPEUTICS, INC. | Chief Executive Officer | 14/08/2018 | - |
| Director/Board Member | 14/08/2018 | 11/08/2023 | |
| Director of Finance/CFO | - | 18/02/2022 | |
| President | 14/08/2018 | 11/08/2023 | |
| CRINETICS PHARMACEUTICALS, INC. | Director/Board Member | 03/01/2022 | - |
| Independent Dir/Board Member | 03/01/2022 | - |
Storia della carriera di Rogério Vivaldi Coelho
Precedenti posizioni note di Rogério Vivaldi Coelho
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOVERATIV INC | Corporate Officer/Principal | 01/01/2016 | 01/01/2018 |
| SPARK THERAPEUTICS, INC. | Director/Board Member | 01/04/2014 | 05/01/2015 |
| Independent Dir/Board Member | 01/04/2014 | 05/01/2015 | |
| Corporate Officer/Principal | 01/04/2014 | 01/01/2016 | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/1997 | - |
| MINERVA NEUROSCIENCES, INC. | Director/Board Member | 23/04/2007 | 05/11/2014 |
| Chief Executive Officer | 23/04/2007 | 20/11/2014 | |
| Founder | 23/04/2007 | 20/11/2014 | |
| President | 23/04/2007 | 05/11/2014 | |
Mind-NRG SARL
 Mind-NRG SARL Medical/Nursing ServicesHealth Services Mind-NRG SARL specializes in research and development programs with focus on the treatment psychiatric and neurologic diseases. The company was founded in 2010 and is headquartered in Geneva, Switzerland. | Director/Board Member | - | 20/11/2014 |
Formazione di Rogério Vivaldi Coelho
| Federal University of Rio de Janeiro | Doctorate Degree |
| COPPEAD Graduate School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Brasile | 3 |
| Svizzera | 2 |
Posizioni
| Director/Board Member | 5 |
| Corporate Officer/Principal | 3 |
| Independent Dir/Board Member | 2 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MINERVA NEUROSCIENCES, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Mind-NRG SARL
Mind-NRG SARL Medical/Nursing ServicesHealth Services Mind-NRG SARL specializes in research and development programs with focus on the treatment psychiatric and neurologic diseases. The company was founded in 2010 and is headquartered in Geneva, Switzerland. | Health Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
